Kevin M. Picardat

Array ( [id] => 536669 [patent_doc_number] => 07176279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Cyclic peptide compositions and methods for treatment of sexual dysfunction' [patent_app_type] => utility [patent_app_number] => 10/638071 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17290 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176279.pdf [firstpage_image] =>[orig_patent_app_number] => 10638071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216781 [patent_doc_number] => 20040071736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Methods and compounds for the treatment of mucus hypersecretion' [patent_app_type] => new [patent_app_number] => 10/633698 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7473 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20040071736.pdf [firstpage_image] =>[orig_patent_app_number] => 10633698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 642170 [patent_doc_number] => 07122623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-17 [patent_title] => 'Compounds and methods for modulating cell adhesion' [patent_app_type] => utility [patent_app_number] => 10/632678 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 109 [patent_no_of_words] => 54816 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122623.pdf [firstpage_image] =>[orig_patent_app_number] => 10632678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 956365 [patent_doc_number] => 06956116 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-18 [patent_title] => 'Pesticidal toxins and genes from Bacillus laterosporus strains' [patent_app_type] => utility [patent_app_number] => 10/631407 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12329 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/956/06956116.pdf [firstpage_image] =>[orig_patent_app_number] => 10631407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 492191 [patent_doc_number] => 07211262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Burn pain treatment by peripheral administration of a neurotoxin' [patent_app_type] => utility [patent_app_number] => 10/630604 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14659 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211262.pdf [firstpage_image] =>[orig_patent_app_number] => 10630604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 871454 [patent_doc_number] => 07361358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-22 [patent_title] => 'Treatment of a facial pain by peripheral administration of a neurotoxin' [patent_app_type] => utility [patent_app_number] => 10/630206 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14657 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/361/07361358.pdf [firstpage_image] =>[orig_patent_app_number] => 10630206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395628 [patent_doc_number] => 20040018212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Joint pain treatment by peripheral administration of a neurotoxin' [patent_app_type] => new [patent_app_number] => 10/630204 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14739 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018212.pdf [firstpage_image] =>[orig_patent_app_number] => 10630204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 532079 [patent_doc_number] => 07172763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Post-operative pain treatment by peripheral administration of a neurotoxin' [patent_app_type] => utility [patent_app_number] => 10/630587 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14653 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/172/07172763.pdf [firstpage_image] =>[orig_patent_app_number] => 10630587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367260 [patent_doc_number] => 20040092447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Uses of kappa-conotoxin PVIIA' [patent_app_type] => new [patent_app_number] => 10/627685 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10833 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 952 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092447.pdf [firstpage_image] =>[orig_patent_app_number] => 10627685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 720154 [patent_doc_number] => 07049293 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Peptide and osteogenetic accelerator' [patent_app_type] => utility [patent_app_number] => 10/619910 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5966 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049293.pdf [firstpage_image] =>[orig_patent_app_number] => 10619910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 540861 [patent_doc_number] => 07169582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display' [patent_app_type] => utility [patent_app_number] => 10/617208 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27322 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169582.pdf [firstpage_image] =>[orig_patent_app_number] => 10617208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7358800 [patent_doc_number] => 20040014151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display' [patent_app_type] => new [patent_app_number] => 10/617012 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26905 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014151.pdf [firstpage_image] =>[orig_patent_app_number] => 10617012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318712 [patent_doc_number] => 07521422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Use of aspartic proteases in cosmetics and therapeutics' [patent_app_type] => utility [patent_app_number] => 10/520521 [patent_app_country] => US [patent_app_date] => 2003-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12397 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521422.pdf [firstpage_image] =>[orig_patent_app_number] => 10520521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6940002 [patent_doc_number] => 20050113565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Pegylated factor VII glycoforms' [patent_app_type] => utility [patent_app_number] => 10/609701 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17195 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113565.pdf [firstpage_image] =>[orig_patent_app_number] => 10609701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7452865 [patent_doc_number] => 20040067889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Stabilization of brain natriuretic peptide (BNP) in blood samples, methods and compositions related thereto' [patent_app_type] => new [patent_app_number] => 10/465691 [patent_app_country] => US [patent_app_date] => 2003-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10715 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067889.pdf [firstpage_image] =>[orig_patent_app_number] => 10465691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102286 [patent_doc_number] => 07723084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Fibrous protein-immobilization systems' [patent_app_type] => utility [patent_app_number] => 10/519216 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5870 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723084.pdf [firstpage_image] =>[orig_patent_app_number] => 10519216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122364 [patent_doc_number] => 20050014193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Identification of target-specific folding sites in peptides and proteins' [patent_app_type] => utility [patent_app_number] => 10/464117 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26990 [patent_no_of_claims] => 207 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014193.pdf [firstpage_image] =>[orig_patent_app_number] => 10464117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467635 [patent_doc_number] => 20040053841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents' [patent_app_type] => new [patent_app_number] => 10/456947 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17286 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053841.pdf [firstpage_image] =>[orig_patent_app_number] => 10456947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770354 [patent_doc_number] => 20030216294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Synergistic effect of a sulfonylurea and/or non-sulfonylurea Kchannel blocker, and a phosphodiesterase 3 type inhibitor' [patent_app_type] => new [patent_app_number] => 10/456371 [patent_app_country] => US [patent_app_date] => 2003-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11922 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216294.pdf [firstpage_image] =>[orig_patent_app_number] => 10456371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 570465 [patent_doc_number] => 07459164 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Composition for therapeutic and cosmetic botulinum toxin' [patent_app_type] => utility [patent_app_number] => 10/446562 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2880 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459164.pdf [firstpage_image] =>[orig_patent_app_number] => 10446562 [rel_patent_id] =>[rel_patent_doc_number] =>)